MITF and melanoma: Importantly, we also observed a significant correlation across 474 patient melanoma samples from TCGA (Fig. 3C), suggesting that the MITF-driven redox program is relevant in-patient biopsies despite the presence of non-malignant stromal and immune cell populations.